Home » Valeant Pharma Acquires Rights for Skin Medications in US, Canada, Mexico
Valeant Pharma Acquires Rights for Skin Medications in US, Canada, Mexico
Valeant Pharmaceuticals International said Thursday it will pay $76 million plus additional royalties to acquire the marketing rights to skin medications Elidel and Xerese for the U.S., Canada and Mexico markets.
Winnipeg Free Press
Winnipeg Free Press
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May